Cell Cure Neurosciences Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 8

Cell Cure Neurosciences General Information

Description

Developer of human cell-based therapies intended for the treatment of retinal and neural degenerative diseases. The company's technology platform is based on the manufacture of diverse cell products sourced from clinical grade human embryonic stem cells, enabling the doctors to find better and new treatment of macular degeneration, Parkinson's disease and multiple sclerosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • POB 12247
  • Jerusalem 91121
  • Israel
+972
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • POB 12247
  • Jerusalem 91121
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell Cure Neurosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cell Cure Neurosciences‘s full profile, request access.

Request a free trial

Cell Cure Neurosciences Patents

Cell Cure Neurosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240285693-A1 Expansion of retinal pigment epithelium cells Pending 28-Jul-2021
US-20230119816-A1 Retinal pigment epithelium cell compositions Pending 29-Dec-2017
EP-4000568-A1 Retinal pigment epithelium cell compositions Pending 29-Dec-2017
US-20220095608-A1 Retinal pigment epithelium cell compositions Inactive 29-Dec-2017
US-20220408719-A1 Retinal pigment epithelium cell compositions Inactive 29-Dec-2017 A61K35/30
To view Cell Cure Neurosciences’s complete patent history, request access »

Cell Cure Neurosciences Executive Team (3)

Name Title Board Seat
Benjamin Reubinoff MD Chief Scientific Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Cell Cure Neurosciences Board Members (5)

Name Representing Role Since
Lineage Cell Therapeutics Board Member
Cell Cure Neurosciences Chairman of the Board
Self Board Member
Self Board Member
You’re viewing 4 of 5 board members. Get the full list »

Cell Cure Neurosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cell Cure Neurosciences‘s full profile, request access.

Request a free trial

Cell Cure Neurosciences FAQs

  • When was Cell Cure Neurosciences founded?

    Cell Cure Neurosciences was founded in 2005.

  • Where is Cell Cure Neurosciences headquartered?

    Cell Cure Neurosciences is headquartered in Jerusalem, Israel.

  • What industry is Cell Cure Neurosciences in?

    Cell Cure Neurosciences’s primary industry is Biotechnology.

  • Is Cell Cure Neurosciences a private or public company?

    Cell Cure Neurosciences is a Private company.

  • What is the current valuation of Cell Cure Neurosciences?

    The current valuation of Cell Cure Neurosciences is .

  • What is Cell Cure Neurosciences’s current revenue?

    The current revenue for Cell Cure Neurosciences is .

  • How much funding has Cell Cure Neurosciences raised over time?

    Cell Cure Neurosciences has raised $4.1M.

  • Who are Cell Cure Neurosciences’s investors?

    Israel Innovation Authority and Teva Pharmaceutical Industries have invested in Cell Cure Neurosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »